Novel approaches and challenges to treatment of central nervous system viral infections - Test2 - elhamkhani - TriplyDB

Novel approaches and challenges to treatment of central nervous system viral infections

Novel approaches and challenges to treatment of central nervous system viral infections

http://www.wikidata.org/entity/Q26862449

about

Vaccinations for Neuroinfectious Disease: A Global Health Priority Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells How to approach and treat viral infections in ICU patients Cell-penetrating and neurotargeting dendritic siRNA nanostructures.West Nile virus state of the art report of MALWEST Project.Neuroinfectious diseases: a crisis in neurology and a call for action.Rabies vaccines: where do we stand, where are we heading?Grand Challenges in Neuroinfectious Diseases.New advances in CNS immunity against viral infection.Viral diseases of the central nervous system Dendritische Nanostrukturen zur rezeptorvermittelten Aufnahme von siRNA in neurale Zellen

P2860

Q26252588-45017C9E-3C22-4551-B57E-1B6B1898A59C Q27308832-107476A4-FA88-43E1-A8E5-9D4D9AD9C014 Q34894660-AD36C2DB-D119-4280-8A3F-3F8A5A09D0CD Q35529832-4269B258-EACE-494D-AE19-4ECD0C11DE45 Q37434776-A2BE8595-3899-481D-9CB8-949909F2DBB9 Q37608252-A809DD01-FAF9-4176-95EB-749B8D4803D8 Q38263028-0CF476DD-C6FF-40FB-BB08-A1E9B3E60B04 Q42360498-0D4AE637-8445-4A49-B4A6-503582484600 Q47559442-95607104-DE90-4FCE-BDA4-006DCD79543A Q56893328-9EA6632B-2BF8-44DC-9A4C-1E999FA39B6B Q57077871-8138F86D-AFDF-46E3-809D-9D174018CC71

P2860

Novel approaches and challenges to treatment of central nervous system viral infections

http://www.wikidata.org/entity/Q26862449

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Novel approaches and challenges to treatment of central nervous system viral infections

@ast

Novel approaches and challenges to treatment of central nervous system viral infections

@en

Novel approaches and challenges to treatment of central nervous system viral infections

@nl

type

label

Novel approaches and challenges to treatment of central nervous system viral infections

@ast

Novel approaches and challenges to treatment of central nervous system viral infections

@en

Novel approaches and challenges to treatment of central nervous system viral infections

@nl

prefLabel

Novel approaches and challenges to treatment of central nervous system viral infections

@ast

Novel approaches and challenges to treatment of central nervous system viral infections

@en

Novel approaches and challenges to treatment of central nervous system viral infections

@nl

P1433

Q26862449-269C0CDE-291C-43C9-8B44-066E5B3CF732

P1476

Q26862449-9EF8B311-5889-4090-A7DC-FF09C1672C03

P2093

Q26862449-27C93E72-449E-4F88-A364-1808FC7F3A01

Q26862449-864FF85C-AE3E-464B-9490-1F8F6884AC18

P2860

Q26862449-01B1830A-BAF4-4EAD-A6E8-1F799A94506D

Q26862449-05B541CC-0B67-489E-A18F-F28276B50843

Q26862449-06A0C029-DB70-4044-9A84-4E9C7456B5E3

Q26862449-085890EE-66EC-432E-A66C-4B2B51CF5C75

Q26862449-091D2931-1B01-4133-A114-BBDC1ADA305B

Q26862449-10565B1F-B865-4E7D-B983-ACE4EF2B4FC6

Q26862449-112D1D4C-4B8E-44D5-8575-4DB12A6A79FF

Q26862449-14067900-B63B-47A4-802E-4F6782F37910

Q26862449-169BC52D-0817-41AF-96AF-C8AFC8EB167B

Q26862449-18D50FAE-C68F-4093-97FF-D5C8C10A5BBC

P304

Q26862449-604B3C0D-CB56-4A17-80D2-457356215F7F

P31

Q26862449-1E2B59A8-4453-455E-8402-686C3161D75B

P356

Q26862449-A0B0C8AA-C68F-462B-98E8-9E73613A9FC6

P407

Q26862449-0F65E4BA-3074-4BAD-8832-BEEF0BD753E7

P433

Q26862449-A46BD2A6-D72F-429B-9EBF-C468A425529F

P478

Q26862449-95BDE648-307C-453A-9C8D-0167914333A2

P577

Q26862449-8944F4E8-BAFE-4668-B9DB-2B5CDB10C2B7

P5875

Q26862449-C134EB84-AA3E-467F-A507-9216E702C492

P698

Q26862449-BFF25768-8E0A-4FEC-9D2F-B53A7D9D37DD

P932

Q26862449-19346A8B-B6F8-4892-B610-C6C2487038C4

P356

P1433

Annals of Neurology

P1476

Novel approaches and challenges to treatment of central nervous system viral infections

@en

P2093

Avindra Nath

http://www.w3.org/2001/XMLSchema#string

Kenneth L. Tyler

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular targets for flavivirus drug discovery

Eradication of HIV from the brain: reasons for pause

Oral acyclovir suppression and neurodevelopment after neonatal herpes

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults

CCR5 deficiency increases risk of symptomatic West Nile virus infection

In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus

A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice

Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival

Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo

P304

412-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.23988

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264662473

http://www.w3.org/2001/XMLSchema#string

P698

23913580

http://www.w3.org/2001/XMLSchema#string

P932

4052367

http://www.w3.org/2001/XMLSchema#string